A Biotech Slump Is Emptying Labs and Threatening Research on New Drugs

Eisai Alzheimer Drug Shows Promise in Injected-At-Home Form

Merck Discontinues Developing Drug Candidates With Sichuan Kelun After Daiichi Sankyo Deal